Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Dogru Ersoz, S. Pekcan, E. Yalcin, U. Ozcelik, N. Kiper, N. Gurcan, B. Sener (Ankara, Konya, Turkey). The role of serum pseudomonas aeruginosa antibodies in diagnosis and follow-up of patients with cystic fibrosis. Eur Respir J 2011; 38: Suppl. 55, 4294

Member's Comments

No comment yet.

Related content which might interest you: Role of serum AGE/RAGEs in the differential diagnosis of pulmonary fibrosis Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 KL-6 serum levels in adult cystic fibrosis patients Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 The diagnosis of cystic fibrosis in adult COPD patients. A survey of 54 patients Source: Eur Respir J 2001; 18: Suppl. 33, 215s Year: 2001 Serum bactericidal activity in non cystic fibrosis bronchiectasis in patients with pseudomonas aeruginosa colonisation Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort Source: Eur Respir J, 55 (4) 1901694; 10.1183/13993003.01694-2019 Year: 2020 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 Pneumococcal antibody levels in children with cystic fibrosis (CF) Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004 Usefulness of long term treatment with azithromycin in patients with bronchiectasis (non cystic fibrosis) Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Early renal involvement in children with cystic fibrosis. Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Characteristics of cystic fibrosis patients diagnosed after false negative cystic fibrosis newborn screening results Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 Clinical significance of serum CA 15-3 in patients with idiopathic interstitial pneumonias Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties Year: 2007 Comparison of clinical features in patients with cystic fibrosis according to the age at diagnosis Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry Source: Eur Respir J, 56 (2) 1902279; 10.1183/13993003.02279-2019 Year: 2020 Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Long-term course of lung clearance index among patients with cystic fibrosis Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment Year: 2020 Impact of other risk factors than age at diagnosis on outcome in cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Magnetic-resonance-imaging (MRI) for assessment of regional therapy response in patients with cystic fibrosis (CF) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009